Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:

Grant Amount: UP TO $1.5M FOR UP TO 3 YRS
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: Jan 24, 2017
Sponsor's: Jan 31, 2017

Subject Areas: Prostate Cancer

Prostate Cancer Canada (PCC) invites applications for investigator-initiated Translation Acceleration Grants (TAG). This request for applications (RFA) solicits proposals from groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer. Projects should be aimed at eliminating advanced disease from affected men and must have the potential to enter clinical trials within 5 years of the beginning of the funding period.

Projects in this area may include, but are not limited to novel agents, immunotherapies, or combinatorial/multimodality therapies and the focus should be on validating an existing agent to treat advanced prostate cancer. The clinical validation of the therapeutic should be attainable through the period of study, and in each case a clear path to clinical application should be proposed. It is expected that a multidisciplinary approach will be required and each TAG2 application may consist of independent investigators based in multiple institutions with a lead Principal Investigator. PCC will only consider projects that are completely focused on prostate cancer

Application Details:

This funding opportunity has a two-step application process. Step 1 requires registration to the competition; step 2 requires the completion of a full application. See sponsor website for annual deadline dates. Access the online application is available at:

Applications are submitted via Smartsimple: It is critical that all applicants follow the instructions outlined in the Submission Information section of the RFA Conformance to all requirements is strictly enforced. Applications that do not comply with these instructions may not be accepted for review.


NOTE: All Letters of Intent and Full Applications must be processed through Research Development & Services for institutional approval. Requests for Institutional approvals should be received no less than 3 days prior to the posted Sponsor deadline. A ROLA Proposal (bearing applicant, Chair and Dean electronic approvals) is required for each submission.
Western Contacts: Moxey,Laura

Sponsor Contacts:

2 Lombard Street, 3rd Floor
TORONTO, Ontario, Canada
416 441-2131